Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK) - Cui, J J; Tran-Dubé, M; Shen, H (J Med Chem, 2011)
, et al.